| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antiplatelet Therapy in End-stage Renal Disease Patients on Maintenance Dialysis: a State-of-the-art Review
|
Ponchia, Pietro Igor
|
|
|
37 |
5 |
p. 975-987
|
artikel
|
| 2 |
CircPCNX Promotes PDGF-BB-Induced Proliferation and Migration of Human Aortic Vascular Smooth Muscle Cells Through Regulating miR-1278/DNMT1 Axis
|
Ma, Wenbin
|
|
|
37 |
5 |
p. 877-889
|
artikel
|
| 3 |
Comparison of Evolocumab and Ezetimibe, Both Combined with Statin Therapy, for Patients with Recent Acute Coronary Syndrome: A Cost-Effectiveness Analysis from the Chinese Healthcare Perspective
|
Xi, Xiaoyu
|
|
|
37 |
5 |
p. 905-916
|
artikel
|
| 4 |
Considerations for Left Atrial Appendage Occlusion During Cardiac Surgery
|
Sylvester, Christopher B.
|
|
|
37 |
5 |
p. 1011-1019
|
artikel
|
| 5 |
C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study
|
Kojima, Sunao
|
|
|
37 |
5 |
p. 965-974
|
artikel
|
| 6 |
CXCR7 Agonist TC14012 Improves Angiogenic Function of Endothelial Progenitor Cells via Activating Akt/eNOS Pathway and Promotes Ischemic Angiogenesis in Diabetic Limb Ischemia
|
Wang, Kai
|
|
|
37 |
5 |
p. 849-863
|
artikel
|
| 7 |
Effect of PCSK9 Monoclonal Antibody Versus Placebo/Ezetimibe on Atrial Fibrillation in Patients at High Cardiovascular Risk: A Meta-Analysis of 26 Randomized Controlled Trials
|
Yang, Shuai
|
|
|
37 |
5 |
p. 927-940
|
artikel
|
| 8 |
Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI
|
Vallejo-Vaz, Antonio J.
|
|
|
37 |
5 |
p. 941-953
|
artikel
|
| 9 |
Long-term Dexamethasone Treatment Increases Cardiac Galectin-3 Levels
|
Akin, Senay
|
|
|
37 |
5 |
p. 1027-1029
|
artikel
|
| 10 |
Mechanobiology of the endothelium in vascular health and disease: in vitro shear stress models
|
Jackson, Molly L.
|
|
|
37 |
5 |
p. 997-1010
|
artikel
|
| 11 |
Mesenchymal Stem Cell–Originated Exosomal Lnc A2M-AS1 Alleviates Hypoxia/Reperfusion-Induced Apoptosis and Oxidative Stress in Cardiomyocytes
|
Yu, Hang
|
|
|
37 |
5 |
p. 891-904
|
artikel
|
| 12 |
Platelet Inhibition with Ticagrelor 60 mg Versus 90 mg Twice Daily in Elderly Patients with Acute Coronary Syndrome: Rationale and Design of the PLINY THE ELDER Trial
|
Piccolo, Raffaele
|
|
|
37 |
5 |
p. 1031-1038
|
artikel
|
| 13 |
Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor
|
Lieder, Helmut Raphael
|
|
|
37 |
5 |
p. 865-876
|
artikel
|
| 14 |
Reply to the Letter to the Editor Titled “The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?” by Han et al
|
Akin, Senay
|
|
|
37 |
5 |
p. 845-846
|
artikel
|
| 15 |
SGLT2-Inhibitors on HFpEF Patients. Role of Ejection Fraction
|
Requena-Ibanez, Juan Antonio
|
|
|
37 |
5 |
p. 989-996
|
artikel
|
| 16 |
Simvastatin, but Not Atorvastatin, Is Associated with Higher Peak Rivaroxaban Serum Levels and Bleeding: an Asian Cohort Study from Singapore
|
Soh, Xin Qin
|
|
|
37 |
5 |
p. 917-925
|
artikel
|
| 17 |
Targeted Mobilisation of Endogenous Endothelial Progenitor Cells — an Alternate Approach to Allogeneic Therapy for Ischaemic Cardiovasular Disease?
|
O’Neill, Karla M.
|
|
|
37 |
5 |
p. 839-841
|
artikel
|
| 18 |
Teriflunomide treatment exacerbates cardiac ischemia reperfusion injury in isolated rat hearts
|
Alexander, Emily Davis
|
|
|
37 |
5 |
p. 1021-1026
|
artikel
|
| 19 |
The Effects of Dexamethasone on Cardiovascular Disease: Friend or Foe?
|
Han, Qian-Feng
|
|
|
37 |
5 |
p. 847-848
|
artikel
|
| 20 |
The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients
|
El-khodary, Noha M.
|
|
|
37 |
5 |
p. 955-964
|
artikel
|
| 21 |
Trimetazidine to Reduce Myocardial Fibrosis—Competing Interests with SGLT2 Inhibitors?
|
Moran, Tyler B.
|
|
|
37 |
5 |
p. 843-844
|
artikel
|
Tijdschrift beschrijving